Levomedetomidine d8
| Product Name | Levomedetomidine d8 |
|---|---|
| Alternate Names | Detomidine Stable Isotopes, Stable Isotopes of Detomidine |
| CAT No. | CS-O-35846 |
| CAS No. | 119717-21-4 (Unlabeled) |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 208.33 g/mol |
| Mol. For. | C13H8D8N2 |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Detomidine |
| Canonical Smiles | CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C |
| InchIKey | CUHVIMMYOGQXCV-LLVKDONJSA-N |
| Inchl | InChI=1S/C13H16N2/c1-9-5-4-6-12(10(9)2)11(3)13-7-14-8-15-13/h4-8,11H,1-3H3,(H,14,15)/t11-/m1/s1 |
| IUPAC | 5-[(1R)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Levomedetomidine d8 is a synthetic analogue of medetomidine, a potent alpha-2 adrenergic receptor agonist used in veterinary medicine for sedation and analgesia. Levomedetomidine d8 is a deuterated version of this compound, where eight hydrogen atoms have been replaced with deuterium atoms. This modification provides several advantages, including increased stability and improved pharmacokinetic properties.
Levomedetomidine d8 is primarily used in preclinical research as a tracer for studying the pharmacokinetics and metabolism of medetomidine in vivo. It is also used in drug metabolism studies to evaluate the pharmacokinetics, bioavailability, and clearance of medetomidine and other alpha-2 adrenergic receptor agonists.
Chemically, Levomedetomidine d8 is a clear, colorless liquid that is stable under normal conditions. It has a molecular weight of 224.43 g/mol and a chemical formula of C14H16D8N3. The compound is typically administered intravenously or intramuscularly, and its effects last for several hours.
Overall, Levomedetomidine d8 is a valuable tool for preclinical researchers studying the pharmacokinetics and metabolism of medetomidine and related compounds. Its deuterated structure provides improved stability and pharmacokinetic properties, making it an ideal tracer for use in animal studies.
Get an Instant Quote
Related Compounds
Medetomidine-D5 | Dexmedetomidine D3 Tartrate | Dexmedetomidine D6 | Medetomidine-d3 Hydrochloride | Medetomidine 13C D3 Hydrochloride |